Cargando…
The Value of Anlotinib in the Treatment of Intractable Brain Edema: Two Case Reports
About 20-30 percent of patients with cancer, such as non-small cell lung cancer, breast cancer, melanoma and renal cell carcinoma, will develop brain metastases (BM). Primary and secondary brain tumors are often accompanied by peritumoral edema. Due to the limited intracranial space, peritumoral ede...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020902/ https://www.ncbi.nlm.nih.gov/pubmed/33828975 http://dx.doi.org/10.3389/fonc.2021.617803 |